The Adjuvant Breast Cancer Therapy Market is expected to grow at a CAGR of 8% during the forecast period, 2022-2028. Adjuvant therapy for breast cancer is designed to treat micrometastatic disease or breast cancer cells that have escaped the breast and regional lymph nodes but have not yet identified identifiable metastases. Adjuvant therapy is often […]
